Finance

Lists
8HA:FRA
Arch Biopartners Inc
€0.61
+4.48%
(+0.026) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8HA...
Open
€0.61
High
€0.61
Low
€0.61
Mkt. cap
69.29M
Avg. vol.
33.00
Volume
0.00
52-wk high
€0.74
52-wk low
€0.25
Open
€0.61
High
€0.61
Low
€0.61
Mkt. cap
69.29M
Avg. vol.
33.00
Volume
0.00
52-wk high
€0.74
52-wk low
€0.25
About Arch Biopartners Inc
CEO-
Employees-
Founded1983
HeadquartersToronto, Ontario, Canada
SectorHealth care
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-138.14K
502.15K
161.51K
25.89K
Cost of revenue
-138.14K
502.15K
161.51K
25.89K
Research and development expenses
-
-
-
192.42K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
268.24K
178.75K
246.77K
198.57K
Operating expense
313.98K
958.41K
246.77K
400.41K
Total operating expenses
175.84K
1.46M
408.28K
426.30K
Operating income
-175.84K
-1.46M
-408.28K
-426.30K
Other non operating income
-41.07K
-19.48K
-51.14K
-11.62K
EBT including unusual items
-269.76K
-1.56M
-521.01K
-475.11K
EBT excluding unusual items
-269.76K
-1.56M
-521.01K
-475.11K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-269.76K
-1.56M
-521.01K
-475.11K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-62.29K
-85.16K
-52.23K
-34.25K
Net interest expenses
-62.29K
-85.16K
-52.23K
-34.25K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps